Boston Scientific Corp. (BSX.N: Quote, Profile, Research), which expects shortly to complete its acquisition of Guidant Corp. (GDT.N: Quote, Profile, Research), on Tuesday said quarterly net earnings fell 7.3 percent on slower sales of its devices to
http://c.moreover.com/click/here.pl?r510530008
http://c.moreover.com/click/here.pl?r510530008